Hyperion Therapeutics, Inc. is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat disorders in the areas of orphan diseases and hepatology. Hyperion is currently developing Ravicti™ (glycerol phenylbutyrate), formerly known as HPN-100, for ...
Use this information to figure out if this company is an ideal customer for you.
(650) 745-xxxx
601 Gateway Blvd
South San Francisco, 94080
The most common Hyperion Therapeutics Inc. email format is [first].[last] (ex. john.doe@hyperiontx.com), currently being used by 88% of Hyperion Therapeutics Inc. business email addresses. There are 7 email formats used by Hyperion Therapeutics Inc..
Hyperion Therapeutics Inc.'s CEO is Chris Rivera
Hyperion Therapeutics Inc.'s HQ is located at 601 Gateway Blvd, South San Francisco
Hyperion Therapeutics Inc.'s phone number is (650) 745-xxxx
Hyperion Therapeutics Inc.'s official website is hyperiontx.com
Hyperion Therapeutics Inc.'s revenue is $1B+
Hyperion Therapeutics Inc. has 51 - 200 employees
Hyperion Therapeutics Inc. is in the industry of: Pharmaceuticals